LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 143

Suchoptionen

  1. Artikel ; Online: Call for Papers: "Targeting Airway Immunity in Lung Disease".

    Bartlett, Nathan W / Feghali-Bostwick, Carol / Gunst, Susan J

    American journal of physiology. Lung cellular and molecular physiology

    2022  Band 324, Heft 1, Seite(n) L48–L52

    Mesh-Begriff(e) Humans ; Respiratory System ; Lung Diseases ; Lung ; Immunity, Innate
    Sprache Englisch
    Erscheinungsdatum 2022-12-06
    Erscheinungsland United States
    Dokumenttyp Editorial
    ZDB-ID 1013184-x
    ISSN 1522-1504 ; 1040-0605
    ISSN (online) 1522-1504
    ISSN 1040-0605
    DOI 10.1152/ajplung.00375.2022
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: An update in club cell biology and its potential relevance to chronic obstructive pulmonary disease.

    Blackburn, Jessica B / Li, Ngan Fung / Bartlett, Nathan W / Richmond, Bradley W

    American journal of physiology. Lung cellular and molecular physiology

    2023  Band 324, Heft 5, Seite(n) L652–L665

    Abstract: Club cells are found in human small airways where they play an important role in immune defense, xenobiotic metabolism, and repair after injury. Over the past few years, data from single-cell RNA sequencing (scRNA-seq) studies has generated new insights ... ...

    Abstract Club cells are found in human small airways where they play an important role in immune defense, xenobiotic metabolism, and repair after injury. Over the past few years, data from single-cell RNA sequencing (scRNA-seq) studies has generated new insights into club cell heterogeneity and function. In this review, we integrate findings from scRNA-seq experiments with earlier in vitro, in vivo, and microscopy studies and highlight the many ways club cells contribute to airway homeostasis. We then discuss evidence for loss of club cells or club cell products in the airways of patients with chronic obstructive pulmonary disease (COPD) and discuss potential mechanisms through which this might occur.
    Mesh-Begriff(e) Humans ; Pulmonary Disease, Chronic Obstructive/metabolism ; Bronchioles/metabolism ; Epithelial Cells/metabolism
    Sprache Englisch
    Erscheinungsdatum 2023-03-21
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 1013184-x
    ISSN 1522-1504 ; 1040-0605
    ISSN (online) 1522-1504
    ISSN 1040-0605
    DOI 10.1152/ajplung.00192.2022
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Understanding Rhinovirus Circulation and Impact on Illness.

    Esneau, Camille / Duff, Alexandra Cate / Bartlett, Nathan W

    Viruses

    2022  Band 14, Heft 1

    Abstract: Rhinoviruses (RVs) have been reported as one of the main viral causes for severe respiratory illnesses that may require hospitalization, competing with the burden of other respiratory viruses such as influenza and RSV in terms of severity, economic cost, ...

    Abstract Rhinoviruses (RVs) have been reported as one of the main viral causes for severe respiratory illnesses that may require hospitalization, competing with the burden of other respiratory viruses such as influenza and RSV in terms of severity, economic cost, and resource utilization. With three species and 169 subtypes, RV presents the greatest diversity within the Enterovirus genus, and despite the efforts of the research community to identify clinically relevant subtypes to target therapeutic strategies, the role of species and subtype in the clinical outcomes of RV infection remains unclear. This review aims to collect and organize data relevant to RV illness in order to find patterns and links with species and/or subtype, with a specific focus on species and subtype diversity in clinical studies typing of respiratory samples.
    Mesh-Begriff(e) Asthma/etiology ; Coinfection/virology ; Enterovirus ; Enterovirus Infections/virology ; Genotyping Techniques ; Hospitalization ; Humans ; Picornaviridae Infections/virology ; Respiratory Tract Infections/virology ; Rhinovirus/classification ; Rhinovirus/genetics ; Serotyping
    Sprache Englisch
    Erscheinungsdatum 2022-01-13
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v14010141
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell.

    Girkin, Jason L N / Maltby, Steven / Bartlett, Nathan W

    European respiratory review : an official journal of the European Respiratory Society

    2022  Band 31, Heft 164

    Abstract: Respiratory virus infections initiate in the upper respiratory tract (URT). Innate immunity is critical for initial control of infection at this site, particularly in the absence of mucosal virus-neutralising antibodies. If the innate immune response is ... ...

    Abstract Respiratory virus infections initiate in the upper respiratory tract (URT). Innate immunity is critical for initial control of infection at this site, particularly in the absence of mucosal virus-neutralising antibodies. If the innate immune response is inadequate, infection can spread to the lower respiratory tract (LRT) causing community-acquired pneumonia (as exemplified by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/coronavirus disease 2019). Vaccines for respiratory viruses (influenza and SARS-CoV-2) leverage systemic adaptive immunity to protect from severe lung disease. However, the URT remains vulnerable to infection, enabling viral transmission and posing an ongoing risk of severe disease in populations that lack effective adaptive immunity.Innate immunity is triggered by host cell recognition of viral pathogen-associated molecular patterns
    Mesh-Begriff(e) Antiviral Agents ; COVID-19 ; Humans ; Immunity, Innate ; Lung ; SARS-CoV-2 ; Toll-Like Receptors
    Chemische Substanzen Antiviral Agents ; Toll-Like Receptors
    Sprache Englisch
    Erscheinungsdatum 2022-05-04
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review
    ZDB-ID 1077620-5
    ISSN 1600-0617 ; 0905-9180
    ISSN (online) 1600-0617
    ISSN 0905-9180
    DOI 10.1183/16000617.0274-2021
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Call for Papers: "In It for the Long Haul: Understanding the Lasting Impact of COVID-19 on Lung Health and Disease".

    Bartlett, Nathan W / Bastarache, Julie A / Kuebler, Wolfgang M / Schmidt, Eric P

    American journal of physiology. Lung cellular and molecular physiology

    2022  Band 323, Heft 6, Seite(n) L683–L684

    Mesh-Begriff(e) Humans ; COVID-19 ; Time Factors ; Lung
    Sprache Englisch
    Erscheinungsdatum 2022-11-08
    Erscheinungsland United States
    Dokumenttyp Editorial
    ZDB-ID 1013184-x
    ISSN 1522-1504 ; 1040-0605
    ISSN (online) 1522-1504
    ISSN 1040-0605
    DOI 10.1152/ajplung.00352.2022
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel: Understanding Rhinovirus Circulation and Impact on Illness

    Esneau, Camille / Duff, Alexandra Cate / Bartlett, Nathan W.

    Viruses. 2022 Jan. 13, v. 14, no. 1

    2022  

    Abstract: Rhinoviruses (RVs) have been reported as one of the main viral causes for severe respiratory illnesses that may require hospitalization, competing with the burden of other respiratory viruses such as influenza and RSV in terms of severity, economic cost, ...

    Abstract Rhinoviruses (RVs) have been reported as one of the main viral causes for severe respiratory illnesses that may require hospitalization, competing with the burden of other respiratory viruses such as influenza and RSV in terms of severity, economic cost, and resource utilization. With three species and 169 subtypes, RV presents the greatest diversity within the Enterovirus genus, and despite the efforts of the research community to identify clinically relevant subtypes to target therapeutic strategies, the role of species and subtype in the clinical outcomes of RV infection remains unclear. This review aims to collect and organize data relevant to RV illness in order to find patterns and links with species and/or subtype, with a specific focus on species and subtype diversity in clinical studies typing of respiratory samples.
    Schlagwörter Enterovirus ; economic costs ; influenza ; therapeutics
    Sprache Englisch
    Erscheinungsverlauf 2022-0113
    Erscheinungsort Multidisciplinary Digital Publishing Institute
    Dokumenttyp Artikel
    ZDB-ID 2516098-9
    ISSN 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v14010141
    Datenquelle NAL Katalog (AGRICOLA)

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: The role of growth factor receptors in viral infections: An opportunity for drug repurposing against emerging viral diseases such as COVID-19?

    Hondermarck, Hubert / Bartlett, Nathan W / Nurcombe, Victor

    FASEB bioAdvances

    2020  Band 2, Heft 5, Seite(n) 296–303

    Abstract: Growth factor receptors are known to be involved in the process of viral infection. Many viruses not only use growth factor receptors to physically attach to the cell surface and internalize, but also divert receptor tyrosine kinase signaling in order to ...

    Abstract Growth factor receptors are known to be involved in the process of viral infection. Many viruses not only use growth factor receptors to physically attach to the cell surface and internalize, but also divert receptor tyrosine kinase signaling in order to replicate. Thus, repurposing drugs that have initially been developed to target growth factor receptors and their signaling in cancer may prove to be a fast track to effective therapies against emerging new viral infections, including the coronavirus disease 19 (COVID-19).
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-04-11
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ISSN 2573-9832
    ISSN (online) 2573-9832
    DOI 10.1096/fba.2020-00015
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Mechanical forces suppress antiviral innate immune responses from asthmatic airway epithelial cells following rhinovirus infection.

    Veerati, Punnam Chander / Reid, Andrew T / Nichol, Kristy S / Wark, Peter A B / Knight, Darryl A / Bartlett, Nathan W / Grainge, Christopher L

    American journal of physiology. Lung cellular and molecular physiology

    2023  Band 325, Heft 2, Seite(n) L206–L214

    Abstract: Bronchoconstriction is the main physiological event in asthma, which leads to worsened clinical symptoms and generates mechanical stress within the airways. Virus infection is the primary cause of exacerbations in people with asthma, however, the impact ... ...

    Abstract Bronchoconstriction is the main physiological event in asthma, which leads to worsened clinical symptoms and generates mechanical stress within the airways. Virus infection is the primary cause of exacerbations in people with asthma, however, the impact that bronchoconstriction itself on host antiviral responses and viral replication is currently not well understood. Here we demonstrate how mechanical forces generated during bronchoconstriction may suppress antiviral responses at the airway epithelium without any difference in viral replication. Primary bronchial epithelial cells from donors with asthma were differentiated at the air-liquid interface. Differentiated cells were apically compressed (30 cmH
    Mesh-Begriff(e) Humans ; Rhinovirus ; Immunity, Innate ; Asthma/metabolism ; Antiviral Agents/pharmacology ; Epithelial Cells/metabolism ; Picornaviridae Infections
    Chemische Substanzen Antiviral Agents
    Sprache Englisch
    Erscheinungsdatum 2023-06-06
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1013184-x
    ISSN 1522-1504 ; 1040-0605
    ISSN (online) 1522-1504
    ISSN 1040-0605
    DOI 10.1152/ajplung.00074.2022
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics.

    Malik, Bilal / Bartlett, Nathan W / Upham, John W / Nichol, Kristy S / Harrington, John / Wark, Peter A B

    Respirology (Carlton, Vic.)

    2023  Band 28, Heft 8, Seite(n) 758–766

    Abstract: Background and objective: Type 2 (T2) innate lymphoid cells (ILC2s) contribute to airway inflammation and disease in asthma. We hypothesize that ILC2s isolated from people with severe allergic and eosinophilic asthma would exhibit an enhanced T2 ... ...

    Abstract Background and objective: Type 2 (T2) innate lymphoid cells (ILC2s) contribute to airway inflammation and disease in asthma. We hypothesize that ILC2s isolated from people with severe allergic and eosinophilic asthma would exhibit an enhanced T2 inflammatory activity that would be altered following treatment with mepolizumab and omalizumab. We compare peripheral blood (PB) isolated ILC2's proliferative capacity, IL-5 and IL-13 secretion and phenotype between healthy without asthma (HC), non-asthma allergic (NAA), mild asthma (MA) and severe allergic and eosinophilic asthma (SA) subjects. We then determined the impact of 6 months treatment with either mepolizumab or omalizumab on ILC2s physiology of SA subjects.
    Methods: ILC2s were sorted and cultured in the presence of IL-2, IL-25, IL-33 and thymic stromal lymphopoietin (TSLP) for 14 days. ILC2s proliferation, phenotypes and functions were assessed using flowcytometry. The ILC2s response was then reassessed following clinically successful treatment of SA subjects with mepolizumab and omalizumab.
    Results: SA ILC2s demonstrated increased proliferative capacity, TSLP receptor (TSLPR), GATA3 and NFATc1 protein expressions and increased IL-5 and IL-13 release. ILC2s were also capable of releasing IL-6 in response to stimulation. Mepolizumab treatment reduced ILC2s proliferative capacity and expression of TSLPR, GATA3 and NFATc1. Both mepolizumab and omalizumab were associated with reduced ILC2s release of IL-5 and IL-13, only mepolizumab reduced IL-6.
    Conclusion: ILC2s from severe allergic and eosinophilic asthma demonstrated an active phenotype typified by increased proliferation, TSLPR, GATA3 and NFATc1 expression and increased IL-5, IL-13 and IL-6 release. Mepolizumab reduced markers of ILC2s activation.
    Mesh-Begriff(e) Humans ; Immunity, Innate ; Interleukin-13 ; Biological Products ; Omalizumab ; Interleukin-5 ; Interleukin-6 ; Lymphocytes ; Asthma/drug therapy ; Cytokines/metabolism ; Pulmonary Eosinophilia ; Cell Proliferation
    Chemische Substanzen Interleukin-13 ; Biological Products ; Omalizumab (2P471X1Z11) ; Interleukin-5 ; Interleukin-6 ; Cytokines
    Sprache Englisch
    Erscheinungsdatum 2023-04-28
    Erscheinungsland Australia
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1435849-9
    ISSN 1440-1843 ; 1323-7799
    ISSN (online) 1440-1843
    ISSN 1323-7799
    DOI 10.1111/resp.14506
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: The role of growth factor receptors in viral infections

    Hubert Hondermarck / Nathan W. Bartlett / Victor Nurcombe

    FASEB BioAdvances, Vol 2, Iss 5, Pp 296-

    An opportunity for drug repurposing against emerging viral diseases such as COVID‐19?

    2020  Band 303

    Abstract: Abstract Growth factor receptors are known to be involved in the process of viral infection. Many viruses not only use growth factor receptors to physically attach to the cell surface and internalize, but also divert receptor tyrosine kinase signaling in ...

    Abstract Abstract Growth factor receptors are known to be involved in the process of viral infection. Many viruses not only use growth factor receptors to physically attach to the cell surface and internalize, but also divert receptor tyrosine kinase signaling in order to replicate. Thus, repurposing drugs that have initially been developed to target growth factor receptors and their signaling in cancer may prove to be a fast track to effective therapies against emerging new viral infections, including the coronavirus disease 19 (COVID‐19).
    Schlagwörter cancer drugs ; COVID‐19 ; growth factors ; heparan sulfate ; heparin ; inhibitors ; Biology (General) ; QH301-705.5 ; covid19
    Sprache Englisch
    Erscheinungsdatum 2020-05-01T00:00:00Z
    Verlag Wiley
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang